Assignee
SIMCERE ZAIMING PHARMACEUTICAL CO LTD
CN·0 granted patents·10 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
10 records- 0154US2024226107A1Ubiquitin-specific protease 1 (usp1) inhibitorSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0254US2025270227A1Camptothecin derivative, and pharmaceutical composition and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0352US2023406922A1Humanized cd19 antibody and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0451US2024124575A1Human cd33 antibody and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0547US2024084003A1Anti-human cd22 monoclonal antibodies and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0646US2023416360A1Anti-cd22 nano antibody and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0743US2024076403A1Her2 antibody and application thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0842US2024301085A1Humanized gpc3 antibody and application thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0940US2024052055A1Gpc3 antibody and application thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1040US2024101686A1Anti-egfr nanobody and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIMCERE ZAIMING PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →